Acute granulomatous acanthamoeba encephalitis in an immunocompetent patient

Neurocrit Care. 2010 Feb;12(1):91-4. doi: 10.1007/s12028-009-9291-z.

Abstract

Background: Acanthamoeba sp. are known to cause fatal granulomatous Acanthamoeba encephalitis (GAE) in immunocompromised patients.

Methods: The case of a 17 year old immunocompetent patient with acute purulent meningoencephalitis is reported.

Results: After substantial improvement of cerebrospinal fluid under conventional antimicrobial treatment the patient was suffering several relapses. The causative agent was identified as Acanthamoeba lenticulata T5 which entered the CNS through a bone dehiscence of ethmoidal cells. Due to severe vasospasm the patient developed multiple strokes, which led to marked neurologic sequels.

Conclusions: This case report demonstrates successful treatment of usually lethal GAE in an immunocompetent patient with high dose meropenem, linezolid, moxifloxacin and fluconazole followed by a partially adapted antimicrobial combination therapy.

Publication types

  • Case Reports

MeSH terms

  • Acanthamoeba*
  • Acute Disease
  • Adolescent
  • Amebiasis / diagnosis*
  • Amebiasis / immunology
  • Amebiasis / therapy
  • Brain Damage, Chronic / diagnosis
  • Central Nervous System Protozoal Infections / diagnosis*
  • Central Nervous System Protozoal Infections / immunology
  • Central Nervous System Protozoal Infections / therapy
  • Cerebrospinal Fluid / parasitology
  • Critical Care
  • Follow-Up Studies
  • Granuloma / diagnosis*
  • Granuloma / immunology
  • Granuloma / therapy
  • Humans
  • Immunocompetence* / immunology
  • Male
  • Tomography, X-Ray Computed